Evaluation of thrombotic left main coronary artery occlusions; old problem, different treatment approaches

Area of Science:

• Cardiology
• Interventional Cardiology
• Vascular Medicine

Background:

• Left main coronary artery (LMCA) thrombosis presents as acute coronary syndrome (ACS), often with severe complications like cardiogenic shock or sudden cardiac death.
• Clinical predictors for LMCA thrombosis are lacking, and optimal treatment strategies remain debated.
• Current treatment options include surgical revascularization (CABG), stenting, thrombolysis, anticoagulation, and thrombus aspiration.

Purpose of the Study:

• To review current literature on thrombotic LMCA occlusions.
• To evaluate emerging treatment strategies, including low-dose, slow-infusion tissue plasminogen activator (tPA).
• To highlight the need for further research and consensus on LMCA thrombosis management.

Main Methods:

• Literature review of thrombotic LMCA occlusions and their management.
• Analysis of reported outcomes for various reperfusion strategies.
• Discussion of a novel low-dose, slow-infusion tPA regimen.

Main Results:

• Thrombotic LMCA occlusions are associated with high mortality and morbidity.
• Various interventions exist, but optimal treatment lacks consensus.
• Successful reperfusion with low-dose, slow-infusion tPA has been reported in hemodynamically stable patients.

Conclusions:

• Thrombotic LMCA obstructions require urgent and effective treatment, but consensus is lacking.
• Low-dose, slow-infusion tPA represents a potential new therapeutic option for selected stable patients.
• Prospective studies are essential to validate this approach and establish optimal treatment guidelines for LMCA thrombosis.